Newsfeed : J&J Urged to License HIV Drugs to Medicines Patent Pool

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » April 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

April 28, 2011

J&J Urged to License HIV Drugs to Medicines Patent Pool

The French charity Doctors Without Borders/Médecins Sans Frontièrs (MSF) published an open letter to Johnson & Johnson (J&J) CEO William C. Weldon urging the company to license all relevant HIV/AIDS patents to the Medicines Patent Pool. In 2010, the Medicines Patent Pool was established by UNITAID, an agency with the mission of buying drugs to fight HIV/AIDS, malaria and tuberculosis. MSF asserts that UNITAID’s ability to manage HIV drug patents collectively will result in better pediatric formulations and fixed dosed combinations. MSF calls on J&J specifically to license rilpivirine, darunavir and etravirine. In January, J&J announced it was not ready to engage in formal negotiations and said that it is contacting generic manufacturers directly.

To read the MSF open letter, click here.

Search: Doctors Without Borders, Médecins Sans Frontièrs, MSF, Johnson & Johnson, J&J, UNITAID, Medicines Patent Pool


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


  comments 1 - 1 (of 1 total)    

Frederick Wright, Southern California, 2011-04-28 21:45:03
Johnson and Johnson also owner of Prezta from Tebo Tech is under firier with this request for many are wondering in this economy will American Bussiness look outside the old models of creating exclusive products with High Profit Margins or will they relize that lowing the prices and selling Billions more pills will increase their profits and save lifes and help save their very souls. SOS, please help the Millions of HIV people ( children women and men)by lower your price.

comments 1 - 1 (of 1 total)    


[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    romanticseattle
    Tacoma
    Washington


    pevans
    San Francisco
    California


    humboman
    Baltimore
    Maryland
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.